吸烟预测无症状颈动脉内膜剥脱术后死亡,但非支架或TCAR
基于VQI数据库2003-2021年63,651例无症状颈动脉狭窄干预患者,经倾向匹配分析发现,CEA术后活动性吸烟者30天和1年死亡率显著高于从不吸烟者,既往吸烟者1年死亡率亦升高;而TFCAS或TCAR术后不同吸烟状态间死亡率无显著差异。多因素回归显示活动性吸烟是CEA术后30天和1年死亡的独立预测因素。
要点
- CEA术后活动性吸烟者30天死亡率0.86% vs 从不吸烟者0.53%(P=0.021)。
- CEA术后活动性吸烟者1年死亡率4.14% vs 从不吸烟者2.58%(P<0.001)。
- TFCAS或TCAR术后不同吸烟状态间死亡率无显著差异。
核心结论
- 吸烟状态是无症状患者CEA术后死亡的独立预测因素,但在TFCAS或TCAR术后不是。
- 研究结果提示,对合适选择的无症状患者,将择期CEA推迟至戒烟至少1个月后可能获益。
研究设计与样本
- 回顾性队列研究,查询Vascular Quality Initiative数据库2003-2021年数据。
- 共纳入63,651例无症状颈动脉狭窄干预患者:CEA 54,953例,TFCAS 3,486例,TCAR 5,212例。
- 按吸烟状态分为从不、既往(戒烟至少1个月)和活动性(术前1个月内吸烟)三组,并进行倾向评分匹配。
主要发现
- CEA术后,活动性吸烟者30天死亡率0.86% vs 从不吸烟者0.53%(P=0.021),1年死亡率4.14% vs 2.58%(P<0.001)。
- CEA术后,既往吸烟者1年死亡率4.28% vs 从不吸烟者3.69%(P=0.023),30天死亡率无显著差异。
- CEA术后,活动性吸烟者术后心肌梗死风险0.57% vs 既往吸烟者0.35%(P=0.013)。
- TFCAS或TCAR术后,不同吸烟状态间死亡率无显著差异。
- TFCAS术后,活动性吸烟者卒中率1.51% vs 既往吸烟者3.14%(P=0.046),其余次要结局无显著差异。
关键数值与推荐
- CEA术后多因素回归:活动性吸烟预测30天死亡(OR 1.44,95%CI 1.05-1.97)和1年死亡(OR 1.52,95%CI 1.32-1.76)。
- CEA术后多因素回归:既往吸烟预测1年死亡(OR 1.26,95%CI 1.12-1.42)。
临床怎么用
- 对无症状颈动脉狭窄患者,评估吸烟状态有助于CEA术后死亡风险分层。
- 研究结果提示,对合适选择的无症状患者,将择期CEA推迟至戒烟至少1个月后可能获益。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To assess the influence of smoking status on mortality for individuals undergoing intervention for asymptomatic carotid artery stenosis. METHODS: The Vascular Quality Initiative database was queried from 2003 to 2021 to identify patients undergoing interventions for asymptomatic carotid artery stenosis with carotid endarterectomy (CEA), transfemoral carotid stenting (TFCAS), or transcarotid artery revascularization (TCAR). Patients were grouped into 3 cohorts: never, former, or active smokers. Active smokers were those who smoked tobacco within 1 month of their procedure, whereas former smokers had quit at least 1 month prior. Propensity matching was then performed adjusting for demographics, comorbidities, preoperative medications, and additional risk factors including anatomic risk, urgency, anesthesia modality, and degree of stenosis. The primary outcomes were 30-day and 1-year mortality. We also evaluated 30-day incidences of transient ischemic attack, stroke, and other complications. Multivariate logistic regression was used to identify independent predictors of mortality. RESULTS: We identified 63,651 patients who underwent carotid artery interventions for asymptomatic stenosis: 54,953 received CEA, 3,486 underwent TFCAS, and 5,212 had TCAR. After propensity score matching, no significant differences persisted in preoperative demographics and risk factors. After CEA, active smokers exhibited significantly higher rates of 30-day (0.86% vs. 0.53%, P = 0.021) and 1-year (4.14% vs. 2.58%, P < 0.001) mortality compared to never smokers. Former smokers also had an increased 1-year mortality compared to never smokers (4.28% vs. 3.69%, P = 0.023), but no significant difference in 30-day mortality. Active smokers also had an increased risk of postoperative myocardial infarction after CEA compared to former smokers (0.57% vs. 0.35%, P = 0.013). No significant differences were observed in mortality between smoking statuses after TFCAS or TCAR. Apart from a reduction in stroke rate in active smokers compared to former smokers in TFCAS (1.51% vs. 3.14%, P = 0.046), no other significant differences were noted in any of the secondary outcomes. On multivariate logistic regression analysis, active smoking was independently predictive of 30-day (odds ratio [OR] 1.44, 95% confidence interval [CI]: 1.05-1.97) and 1-year mortality (OR 1.52, 95% CI: 1.32-1.76), and former smoking was predictive of 1-year mortality (OR 1.26, 95% CI: 1.12-1.42) following CEA. CONCLUSION: Smoking status is an independent predictor of mortality following CEA in asymptomatic patients, but not in either stenting modality. Our findings suggest a potential benefit of postponing elective CEA in appropriately selected asymptomatic patients until at least 1 month of smoking cessation is attained.
引用
- Basilious M, Sarad N, Akosman I, et al. Smoking Predicts Mortality in Asymptomatic Patients Undergoing Carotid Endarterectomy but Not Carotid Artery Stenting or Transcarotid Artery Revascularization. Ann Vasc Surg. 2025. PMID: 40553846. doi:10.1016/j.avsg.2025.05.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。